Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$23.15 - $28.34 $4.19 Million - $5.12 Million
-180,802 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$22.03 - $32.01 $3.24 Million - $4.71 Million
147,202 Added 438.1%
180,802 $4.69 Million
Q3 2018

Nov 14, 2018

BUY
$30.0 - $40.85 $1.01 Million - $1.37 Million
33,600 New
33,600 $1.06 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $127M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Governors Lane LP Portfolio

Follow Governors Lane LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Governors Lane LP, based on Form 13F filings with the SEC.

News

Stay updated on Governors Lane LP with notifications on news.